| Trial Identifier: | D6580C00008 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Parexel International
|
| NCTID:: | NCT04232345 |
| Start Date: | January 2020 |
| Primary Completion Date: | March 2021 |
| Study Completion Date: | March 2021 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English version | |
| Japanese (US) Translation | |
| Simplified Chinese (US) Translation |
| Country | Location |
|---|---|
| United States of America, CA | Glendale, CA, United States of America, 91206 |